[Palliative irradiation in the treatment of breast carcinoma].
It is considered that in 30% of female patients with breast cancer a certain form of evolutive disease occurs within 5 years from documented diagnosis. In these female patients, 58% develop distal metastases. Thus, a great number of these female patients enter the phase when hope for recovery is small. Then supportive therapy is used. It's main task is to alleviate the life of these patients. Palliative radiotherapy is one of the main elements of this therapy. It is directed to decrease the pain, and bleeding, to prevent fractures and decompression of the spinal cord, as well as many other evolution consequences of local or distal disease. The correct and timely definition of indications for radiotherapy, the optimal planning and conduction of the therapy should take into account the patient's characteristics as well as the main postulates on which radiotherapy is based. In this way the satisfying effects on patients with disseminated breast cancer, may be expected.
Borojević
N
N
Institute of Oncology and Radiology of Serbia, Belgrade.
Golubicić
I
I
Radosević-Jelić
Lj
Lj
D001943:Breast Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D010166:Palliative Care
Palijativno zracenje u lecenju karcinoma dojke.